Assessing ethics of trials in systematic reviews

British Medical Journal

Volumn 328, Issue 7446, 2004, Pages 1013-1014

  Weingarten, Michael A ^a   Paul, Mical ^b   Leibovici, Leonard ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM;

CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG SAFETY; FEBRILE NEUTROPENIA; FINANCIAL MANAGEMENT; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; METHODOLOGY; PRIORITY JOURNAL; PUBLISHING; RESEARCH ETHICS; REVIEW; SYSTEMATIC REVIEW;

EID: 1942467882     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7446.1013     Document Type: Review

References (15)

1. Bauchner H, Scharshtein J. Failure to report ethical approval in child health research: review of published papers. BMJ 2001;323:318-9.
2. Pappworth M. Human guinea pigs: experimentation on man. Boston: Beacon, 1967.
3. Seidelman WE. Mengele medicus: medicine's Nazi heritage. Milbank Q 1988;66:221-39.
4. Weitzman M. The ethics of using Nazi medical data. Second Opinion: Health Faith and Ethics 1990;14:27-39.
5. Ruiz-Canela M, Irala-Estevez J, Martinez-Gonzalez MA, Gomez-Gracia E, Fernandez-Crehuet J. Methodological quality and reporting of ethical requirements in clinical trials. J Med Ethics 2001;27:172-6.
6. Foster C. The ethics of medical research on humans. Cambridge: Cambridge University Press, 2001.
7. Freedman B, Fuks A, Weijer C. In loco parentis. Minimal risk as an ethical threshold for research on children. Hastings Cent Rep 1993;23(2):13-9.
8. Doyal L, Tobias JS, eds. Informed consent in medical research. London: BMJ Publications, 2000.
9. Paul M, Soares-Weiser K, Leibovici L. β lactam monotherapy versus β lactam aminoglycoside combination therapy for febrile neutropenia: systematic review and meta-analysis. BMJ 2003;326:1111-5.
10. Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ 1996;313:36-9.
11. Wade JC, Bustamante C, Delin A, Finely R, Drusano G, Thompson B. Imipenem vs piperacillin plus amikacin, empiric therapy for febrile neutropenic patients: a double blind trial [abstract 1251]. Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1987.
12. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, et al. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis. 1990;161:381-96.
13. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-73.
14. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.
15. CONSORT statement for reporting randomised trials. www.consortstatement. org (accessed 24 Feb 2004).